A study to identify novel biomarkers associated with multiple myeloma
Background. multiple myeloma (mm) is a plasma cell cancer that affects white blood cells. plasma cells from the bone marrow grow abnormally, as a consequence of which patients have high amounts of monoclonal immunoglobulin in their blood and urine, poor renal function, and recurring infections due t...
Saved in:
| Main Authors: | Bhaskar Kalarani Iyshwarya, Veerabathiran Ramakrishnan |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2023-11-01
|
| Series: | Сибирский онкологический журнал |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/2767 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nestin in multiple myeloma: emerging insights into a potential therapeutic target
by: Yingmiao Wu, et al.
Published: (2025-07-01) -
Lipid metabolism in multiple myeloma: pathogenesis, therapeutic opportunities, and future directions
by: Huiquan Wang, et al.
Published: (2025-03-01) -
Identification of RUVBL2 as a novel biomarker to predict the prognosis and drug sensitivity in multiple myeloma based on ferroptosis genes
by: Sishi Tang, et al.
Published: (2025-12-01) -
Tregs at Diagnosis as a Potential Biomarker for Predicting High‐Risk Functionality in Newly Diagnosed Multiple Myeloma
by: Qiaolin Zhou, et al.
Published: (2025-06-01) -
Genomic characteristics and prognostic correlations in Chinese multiple myeloma patients
by: Xi Chen, et al.
Published: (2025-03-01)